Nusinersen (Spinraza), an antisense oligonucleotide, was recently approved by the United States Food and Drug Administration (FDA) to treat spinal muscular atrophy (SMA), a rare and often fatal ...
Between 1998 and 2016 prices for “Medical Care Services” in the US (as measured by the BLS’s CPI for Medical Care Services) more than doubled (+100.5% increase) while the prices for “Hospital and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results